Cancer-associated thromboembolism: could direct-acting oral anticoagulants be a promising therapeutic option? Literature review

Categoría del artículo: Research Article

Publicado en línea: 08 sept 2020

Páginas: 22 - 28

Recibido: 25 mar 2019

Aceptado: 28 feb 2020

DOI: https://doi.org/10.2478/fco-2019-0009

Palabras clave

cancer, venous thromboembolic event, CAT, direct oral anticoagulant drugs, DOACs

© 2020 Paraskevi Savvari, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.